Prognostic role of lymphocyte-to-C reactive protein ratio in hepatocellular carcinoma (HCC): A meta-analysis of 4,006 patients

Prognostic role of lymphocyte-to-C reactive protein ratio in hepatocellular carcinoma (HCC): A meta-analysis of 4,006 patients

Bibliographic Details
Main Authors:	Zhengyue He, Boan Lai, Hui Jiang, Ling Yang
Format:	Article
Language:	English
Published:	Elsevier 2023-07-01
Series:	Asian Journal of Surgery
Subjects:	Lymphocyte-to-C-reactive protein ratio Hepatocellular carcinoma Prognosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958423002269

Similar Items

Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Hepatocellular Carcinoma Treated with Stereotactic Body Radiotherapy
by: Younghee Park, et al.
Published: (2022-06-01)

Prognostic Role of Neutrophil-to-Lymphocyte Ratio (NLR), Lymphocyte-to-Monocyte Ratio (LMR), Platelet-to-Lymphocyte Ratio (PLR) and Lymphocyte-to-C Reactive Protein Ratio (LCR) in Patients with Hepatocellular Carcinoma (HCC) undergoing Chemoembolizations (TACE) of the Liver: The Unexplored Corner Linking Tumor Microenvironment, Biomarkers and Interventional Radiology
by: Roberto Minici, et al.
Published: (2022-12-01)

Prognostic Significance of Platelet-lymphocyte Ratio in Hepatocellular Carcinoma Patients: A Meta-analysis
by: ZHANG Tingting, et al.
Published: (2018-10-01)

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
by: Jing-Houng Wang, et al.
Published: (2022-01-01)

Prognostic value of platelet distribution width to lymphocyte ratio in patients with hepatocellular carcinoma following hepatectomy
by: Zhi-Han Zhong, et al.
Published: (2023-11-01)

Predictive value of platelet-to-lymphocyte and neutrophil-to-lymphocyte ratio in HCC treated with sorafenib and radioembolization
by: Osman Öcal, et al.
Published: (2024-04-01)

Prognostic Significant of Neutrophil: Lymphocyte Ratio, Platelet – Lymphocyte ratio, and Lymphocyte – Monocyte ratio in Kurdish Patients with breast cancer
by: S. Khazaei, et al.
Published: (2022-07-01)

Dynamic Changes in the Neutrophil-to-Lymphocyte Ratio Predict the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
by: Wang H, et al.
Published: (2020-05-01)

Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet−to−Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta−analysis
by: Jiali Leng, et al.
Published: (2022-05-01)

The prognostic significance of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in giant cell tumor of the extremities
by: Zhenhao Chen, et al.
Published: (2019-04-01)

Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving Radiotherapy
by: Shi Z, et al.
Published: (2024-02-01)

The prognostic and predictive value of the combination of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma who receive transarterial chemoembolization therapy
by: He C, et al.
Published: (2019-02-01)

Prognostic Role of Lymphocyte-C-Reactive Protein Ratio in Colorectal Cancer: A Systematic Review and Meta Analysis
by: Xinglong He, et al.
Published: (2022-07-01)

Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Systemic Immune-Inflammatory Index in Resected Gastric Cancer
by: Hayriye Şahinli, et al.
Published: (2019-12-01)

Prognostic Value of Neutrophil–Lymphocyte Ratio, Platelet–Lymphocyte Ratio, and Combined Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Stage IV Advanced Gastric Cancer
by: Huan Wang, et al.
Published: (2020-06-01)

Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma
by: Najjar M, et al.
Published: (2018-01-01)

Neutrophil Lymphocyte Ratio to Albumin Ratio and White Blood Cell to Hemoglobin Ratio as Prognostic Markers for Hepatocellular Carcinoma Patients Who Underwent Curative Hepatectomy
by: Shen X, et al.
Published: (2021-08-01)

Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti–PD‐1 therapy
by: Sirish Dharmapuri, et al.
Published: (2020-07-01)

Prognostic Value of Lymphocyte–C-Reactive Protein Ratio in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Population-Based Study
by: Houliang Zhang, et al.
Published: (2021-10-01)

Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma
by: Masateru Yamamoto, et al.
Published: (2019-11-01)

Combining Pre- and Postoperative Lymphocyte–C-Reactive Protein Ratios Can Better Predict Hepatocellular Carcinoma Prognosis After Partial Hepatectomy
by: Ni HH, et al.
Published: (2022-04-01)

Association between Posttreatment Serum Platelet-to-Lymphocyte Ratio and Distant Metastases in Patients with Hepatocellular Carcinoma Receiving Curative Radiation Therapy
by: Dong Soo Lee, et al.
Published: (2023-03-01)

Assessment of C-Reactive Protein, Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients at Different Stages of Chronic Kidney Disease
by: Klapuh-Bukvić Nermina, et al.
Published: (2022-12-01)

Evaluation of the Prognostic Role of Neutrophil-Lymphocyte Ratio, C-Reactive Protein-Albumin Ratio, and Platelet-Lymphocyte Ratio in Patients with the Co-Presentation of Coronary Artery Disease and COVID-19
by: Xu X, et al.
Published: (2024-03-01)

Prognostic value of neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio for breast cancer patients: An updated meta‐analysis of 17079 individuals
by: Wanying Guo, et al.
Published: (2019-08-01)

Lymphocyte-to-C reactive protein ratio as novel inflammatory marker for predicting outcomes in hemodialysis patients: A multicenter observational study
by: Xinpan Chen, et al.
Published: (2023-03-01)

Prognostic Value of Combined Neutrophil-to-Lymphocyte Ratio and Imaging Tumor Capsule in Solitary Hepatocellular Carcinoma Patients after Narrow-Margin Hepatectomy
by: Desheng Chen, et al.
Published: (2024-01-01)

Role of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Predictors Before Treatment for Metastatic Bladder Cancer Patients Receiving First-Line Chemotherapy
by: Oktay Bozkurt, et al.
Published: (2019-09-01)

C-reactive protein-to-albumin ratio is an independent poor prognostic factor in newly diagnosed chronic lymphocytic leukaemia: A clinical analysis of 322 cases
by: Han-Ning Tang, et al.
Published: (2021-04-01)

Significant association between high neutrophil-lymphocyte ratio and poor prognosis in patients with hepatocellular carcinoma: a systematic review and meta-analysis
by: Chunhua Xu, et al.
Published: (2023-09-01)

Prediction of severity of preeclampsia in Egyptian patients: role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and C-reactive protein
by: A. E. Kholeif, et al.
Published: (2020-04-01)

Prognostic value of preoperative inflammatory markers in patients with hepatocellular carcinoma who underwent curative resection
by: Wenlong Wu, et al.
Published: (2021-09-01)

Prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in laryngeal cancer: What should we expect from a meta-analysis?
by: Xianyang Hu, et al.
Published: (2022-08-01)

Breast cancer prognostication with neutrophil–lymphocyte ratio and platelet–lymphocyte ratio
by: Taha Bahgat
Published: (2017-01-01)

Clinical Value and Prognosis of C Reactive Protein to Lymphocyte Ratio in Severe Aneurysmal Subarachnoid Hemorrhage
by: Qingqing Zhang, et al.
Published: (2022-06-01)

Neutrophil to Lymphocyte Ratio in Retroperitoneal Liposarcoma and Other Prognostic Factors
by: FU Yali, et al.
Published: (2019-02-01)

Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Cats With Hypertrophic Cardiomyopathy
by: Ryan C. Fries, et al.
Published: (2022-03-01)

Corrigendum: Clinical value and prognosis of C reactive protein to lymphocyte ratio in severe aneurysmal subarachnoid hemorrhage
by: Qingqing Zhang, et al.
Published: (2022-12-01)

Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I–II gastric cancer
by: Xiaowei Sun, et al.
Published: (2016-06-01)

Prognostic value of the combination of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio and platelet-to-lymphocyte ratio on mortality in patients on maintenance hemodialysis
by: Jiaxian Liao, et al.
Published: (2022-12-01)